How does arginine effect on the course of tuberculosis? Experimental trial
I. Diachkov (Yekaterinburg, Russian Federation), I. Medvinskiy (Yekaterinburg, Russian Federation), E. Sabadash (Yekaterinburg, Russian Federation), S. Skornyakov (Yekaterinburg, Russian Federation), V. Kotomtsev (Yekaterinburg, Russian Federation), V. Pavlov (Yekaterinburg, Russian Federation), E. Ivanchikova (Yekaterinburg, Russian Federation)
Source: International Congress 2018 – Challenges in tuberculosis care
Session: Challenges in tuberculosis care
Session type: Thematic Poster
Number: 2685
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Diachkov (Yekaterinburg, Russian Federation), I. Medvinskiy (Yekaterinburg, Russian Federation), E. Sabadash (Yekaterinburg, Russian Federation), S. Skornyakov (Yekaterinburg, Russian Federation), V. Kotomtsev (Yekaterinburg, Russian Federation), V. Pavlov (Yekaterinburg, Russian Federation), E. Ivanchikova (Yekaterinburg, Russian Federation). How does arginine effect on the course of tuberculosis? Experimental trial. 2685
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The effect of text messaging on latent tuberculosis treatment adherence: a randomised controlled trial Source: Eur Respir J, 51 (2) 1701488; 10.1183/13993003.01488-2017 Year: 2018
Paradoxical reactions during treatment of tuberculosis: A prospective study Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010
Effect of exacerbation history on response to treatment in the TORCH trial Source: Eur Respir J 2007; 30: Suppl. 51, 356s Year: 2007
Supplementation of N-acetylcysteine as an adjuvant in treatment of newly diagnosed pulmonary tuberculosis patients: A prospective, randomized double blind, placebo controlled study Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013
Late Breaking Abstract: High-dose vitamin D3 during intensive phase treatment of pulmonary tuberculosis: A double-blind randomised controlled trial Source: Annual Congress 2010 - Clinical tuberculosis Year: 2010
Routine liver function test monitoring of patients treated for active M.TB infection does not influence management: A real-world retrospective study Source: International Congress 2018 – Challenges in tuberculosis care Year: 2018
Maintenance after pulmonary rehabilitation in COPD: a randomised trial. Preliminary results Source: Eur Respir J 2004; 24: Suppl. 48, 245s Year: 2004
The clinical effect of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease - including a long-term follow-up study Source: Eur Respir J 2004; 24: Suppl. 48, 721s Year: 2004
Feasibility of shortening intravenous antibiotic therapy for bronchiectasis based on bacterial load: a proof-of-concept randomised controlled trial Source: Eur Respir J, 58 (6) 2004388; 10.1183/13993003.04388-2020 Year: 2021
The effect of smoking on the treatment outcome in patients with pulmonary tuberculosis: A prospective cohort study Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011
Experimental hookworm infection as potential therapy for asthma: a randomised placebo controlled trial Source: Annual Congress 2009 - Epidemiology of atopy and asthma Year: 2009
Pulmonary tuberculosis control: does COVID-19 have any effect? Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021
Does hospitalization influence tuberculosis’ treatment outcome? – A Portuguese nationwide study Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria Year: 2018
Effects of distance to treatment centre and case load upon tuberculosis treatment completion Source: Eur Respir J 2011; 38: 1223-1225 Year: 2011
Safety and benefit of adjunctive systemic corticosteroid therapy in the management of severe, smear positive pulmonary tuberculosis (SSP-PTB); an interim analysis of a randomized controlled trial Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012
Granulamatous mastitis treated as tuberculosis: Preliminary results of surveillance programme Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012
A cross-over study to compare the Lung Flute™ to hypertonic saline inhalation about the performance of inducing sputum for the diagnosis of pulmonary tuberculosis Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Effect of vitamin A & zinc supplementation on clinical response &nutritional status in patients with tuberculosis getting standard chemotherapy: a double blind, placebo control study in Bangladesh Source: Eur Respir J 2004; 24: Suppl. 48, 722s Year: 2004
Treatment of latent tuberculosis infection: completion rates and adverse effects Source: Eur Respir J 2003; 22: Suppl. 45, 526s Year: 2003
New short regimens for latent tuberculosis treatment: safety first! Source: Eur Respir J, 52 (6) 1802180; 10.1183/13993003.02180-2018 Year: 2018